Financhill
Back

Perspective Therapeutics Stock Predictions

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!
Sell
30

CATX
Perspective Therapeutics

Last Price:
12.34
Seasonality Move:
26.28%

7 Day Trial

ALL ACCESS PASS

$ 7

U.S. Government Report Alert Tuesday

Discover the Secret Loophole

Perspective Therapeutics Stock Forecast

  • Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 20.4% based on the past 20 years of stock performance.
  • Perspective Therapeutics has risen higher in 6 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%
  • Is Perspective Therapeutics Stock Undervalued?
    The current Perspective Therapeutics [CATX] share price is $12.34. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Perspective Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Perspective Therapeutics has on average historically risen by 20.4% based on the past 20 years of stock performance.

Perspective Therapeutics Stock Rating

Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics overpriced?

  • Perspective Therapeutics has risen higher in 6 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 30%

Perspective Therapeutics Stock Price History

Is CATX stock going to rise?

  • The current trend is relatively stagnant and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYAM
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
perspectivetherapeutics.com

52-Week Data

52-Week High:
19.05
52-Week Low:
2.20

Prediction Charts

Market Cap:
832.06M
Price in USD:
12.34
Volume:
425.87K
Beta:
1.34

Technical Analysis

SMA50:
13.38
SMA100:
12.78
SMA200:
12.62
52-Wk Change:
351.35%

Stock Predictions

  • Is Perspective Therapeutics stock public?
    Yes, Perspective Therapeutics is a publicly traded company.
  • What is the Perspective Therapeutics stock quote today?
    The Perspective Therapeutics stock price is 12.34 USD today.
  • How to buy Perspective Therapeutics stock online?
    You can buy Perspective Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 12.57 13.00 13.15 12.44
Oct-18 12.30 12.65 12.72 11.93
Oct-21 12.57 12.70 12.84 12.40
Oct-22 12.69 12.39 12.69 12.19
Oct-23 12.29 11.69 12.40 11.65
Oct-24 12.28 11.89 12.31 11.80
Oct-25 11.93 11.53 11.96 11.50
Oct-28 11.77 11.91 12.46 11.55
Oct-29 11.76 11.87 12.09 11.69
Oct-30 11.81 11.47 11.94 11.43
Oct-31 11.40 11.81 11.95 11.40
Nov-1 11.97 12.09 12.21 11.64
Nov-4 12.09 12.19 12.90 11.79
Nov-5 12.15 12.34 12.39 11.95

Perspective Therapeutics Earnings

Perspective Therapeutics Earnings Report: Per Share Perspective Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Perspective Therapeutics Forecast Revenue Growth

Perspective Therapeutics Stock Analysis: Historical quarterly revenues per share for Perspective Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.

* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.